×
About 6,200 results

ALLMedicine™ Acne Vulgaris Center

Research & Reviews  1,435 results

Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials.
https://doi.org/10.1080/14728214.2022.2110239
Expert Opinion on Emerging Drugs; Bhatt S, Kothari R et. al.

Aug 6th, 2022 - Acne vulgaris is one of the commonest dermatoses encountered in a dermatology clinic. Although, the inflammatory processes are centered around the pilosebaceous unit, a myriad of external factors that alter the pathogenesis have been hypothesized....

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT01209949

Aug 1st, 2022 - The purpose of this study is to assess subjects' experiences using Adapalene BPO gel to treat mild to moderate acne vulgaris using efficacy measurements, quality of life instruments, and video diaries.

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
https://clinicaltrials.gov/ct2/show/NCT01522456

Aug 1st, 2022 - Adult subjects with acne vulgaris will receive tretinoin gel 0.1% on one side of the face and adapalene 0.1% / benzoyl peroxide 2.5% gel on the other side of the face once daily for a period 3 weeks (22 days). Tolerability assessments (erythema, d...

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT05478330

Jul 28th, 2022 - Flutamide is a non-steroidal anti-androgen, which is used to treat patients with prostate cancer. Due to its anti-androgenic properties can be used in cases of acne, hirsutism, and androgenic alopecia with successful outcomes. To minimize the unne...

see more →

Guidelines  3 results

Management of acne vulgaris: summary of NICE guidance.
https://doi.org/10.1136/bmj.n1800
BMJ (Clinical Research Ed.); Xu J, Mavranezouli I et. al.

Sep 22nd, 2021 - Management of acne vulgaris: summary of NICE guidance.|2021|Xu J,Mavranezouli I,Kuznetsov L,Stephen Murphy M,Healy E,|

Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vu...
https://doi.org/10.1111/1346-8138.14355
The Journal of Dermatology; Hayashi N, Akamatsu H et. al.

May 22nd, 2018 - The Guidelines for the Treatment of Acne Vulgaris of the Japanese Dermatological Association was first published in Japanese in 2008 and revised in 2016 and 2017. These guidelines (GL) indicate the standard acne treatments in Japan and address pha...

Evidence-based recommendations for the diagnosis and treatment of pediatric acne.
https://doi.org/10.1542/peds.2013-0490B
Pediatrics Eichenfield LF, Krakowski AC et. al.

May 3rd, 2013 - Acne vulgaris is one of the most common skin conditions in children and adolescents. The presentation, differential diagnosis, and association of acne with systemic pathology differs by age of presentation. Current acknowledged guidelines for the ...

see more →

Drugs  419 results see all →

Clinicaltrials.gov  379 results

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
https://clinicaltrials.gov/ct2/show/NCT01522456

Aug 1st, 2022 - Adult subjects with acne vulgaris will receive tretinoin gel 0.1% on one side of the face and adapalene 0.1% / benzoyl peroxide 2.5% gel on the other side of the face once daily for a period 3 weeks (22 days). Tolerability assessments (erythema, d...

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT01209949

Aug 1st, 2022 - The purpose of this study is to assess subjects' experiences using Adapalene BPO gel to treat mild to moderate acne vulgaris using efficacy measurements, quality of life instruments, and video diaries.

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT05478330

Jul 28th, 2022 - Flutamide is a non-steroidal anti-androgen, which is used to treat patients with prostate cancer. Due to its anti-androgenic properties can be used in cases of acne, hirsutism, and androgenic alopecia with successful outcomes. To minimize the unne...

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color
https://clinicaltrials.gov/ct2/show/NCT03681470

Jul 27th, 2022 - Acne vulgaris is a common skin disease characterized by inflammatory papules, pustules, and comedones that is prevalent in men and women of color. In fact, acne is the most common dermatologic diagnosis made in SOC populations. Although individual...

see more →

News  243 results

When Isotretinoin Fails: Causes and Treatment Options
https://www.medscape.com/viewarticle/978181

Jul 28th, 2022 - INDIANAPOLIS – When adolescents present with acne that is not responding to isotretinoin, make sure to ask if they’re taking the medication when eating fatty food – which is known to increase the drug’s bioavailability, advises James R. Treat, MD,...

Study Eyes Characteristics of Pediatric Patients With Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/977227

Jul 14th, 2022 - INDIANAPOLIS — Nearly two-thirds of pediatric patients with hidradenitis suppurativa (HS) met criteria for obesity at the time of their diagnosis, and 36% had acne, in a study presented at the annual meeting of the Society for Pediatric Dermatolog...

Adapting to Changes in Acne Management: Take One Step at a Time
https://www.mdedge.com/dermatology/article/256055/acne/adapting-changes-acne-management-take-one-step-time
James Q. Del Rosso, DO

Jul 6th, 2022 - After most dermatology residents graduate from their programs, they go out into practice and will often carry with them what they learned from their teachers, especially clinicians. Everyone else in their dermatology residency programs approaches.

FDA Approvals, Highlights, and Summaries: Dermatology
https://www.medscape.com/viewarticle/967603

Feb 17th, 2022 - Adbry (tralokinumab) Tralokinumab is an interleukin-13 (IL-13) inhibitor that blocks IL-13–induced responses (eg, release of proinflammatory cytokines, chemokines, IgE). It is indicated for moderate-to-severe atopic dermatitis in adults who are no...

Oral Isotretinoin for Acne in the US Military: How Accelerated Courses and Teledermatology Can Minimize the Duty-Limiting Impacts of Treatment
https://www.mdedge.com/dermatology/article/251521/acne/oral-isotretinoin-acne-us-military-how-accelerated-courses-and
Austin M. Park, MD, Catherine Brahe, MD

Feb 7th, 2022 - Acne vulgaris is an extremely common dermatologic disease affecting 40 to 50 million individuals in the United States each year, with a prevalence of 85% in adolescents and young adults aged 12 to 24 years. For some patients, the disease may persi.

see more →

Patient Education  1 results see all →